Active substance
Meclizine
- US FDA 40
- US price lines 7
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ANTIVERT | 50MG; 25MG; 12.5MG | tablet · oral | CASPER PHARMA LLC | Prescription | 14 Feb 1957 |
| ANTIVERT | 25MG | tablet, chewable · oral | CASPER PHARMA LLC | Prescription | 14 Feb 1957 |
| MECLIZINE HYDROCHLORIDE | 25MG | tablet · oral | QUAGEN | Prescription | 19 Mar 1975 |
| MECLIZINE HYDROCHLORIDE | 12.5MG | tablet · oral | SANDOZ | Prescription | 3 Feb 1976 |
| MECLIZINE HYDROCHLORIDE | 25MG; 12.5MG | tablet · oral | SENORES PHARMS | Prescription | 3 Jun 1981 |
| MECLIZINE HYDROCHLORIDE | 12.5MG; 25MG | tablet · oral | JUBILANT CADISTA | Prescription | 4 Jun 2010 |
| MECLIZINE HYDROCHLORIDE | 12.5MG; 25MG; 50MG | tablet · oral | AMNEAL PHARMS | Prescription | 23 Feb 2011 |
| MECLIZINE HYDROCHLORIDE | 12.5MG; 25MG | tablet · oral | EPIC PHARMA LLC | Prescription | 13 Apr 2012 |
| MECLIZINE HYDROCHLORIDE | 12.5MG; 25MG; 50MG | tablet · oral | AUROBINDO PHARMA USA | Prescription | 17 Sep 2012 |
| MECLIZINE HYDROCHLORIDE | 50MG | tablet · oral | HERITAGE | Prescription | 22 Feb 2019 |
| MECLIZINE HYDROCHLORIDE | 12.5MG; 25MG | tablet · oral | ZYDUS LIFESCIENCES | Prescription | 23 Jun 2020 |
| MECLIZINE HYDROCHLORIDE | 12.5MG; 25MG; 50MG | tablet · oral | CHARTWELL RX | Prescription | 11 Aug 2022 |
| MECLIZINE HYDROCHLORIDE | 25MG; 12.5MG | tablet · oral | ANI PHARMS | Discontinued | 1 Dec 1975 |
| MECLIZINE HYDROCHLORIDE | 12.5MG | tablet · oral | IVAX SUB TEVA PHARMS | Discontinued | 5 Dec 1975 |
| MECLIZINE HYDROCHLORIDE | 25MG | tablet, chewable · oral | IVAX SUB TEVA PHARMS | Discontinued | 4 Oct 1976 |
| MECLIZINE HYDROCHLORIDE | 12.5MG | tablet · oral | ANI PHARMS | Discontinued | 11 Nov 1976 |
| MECLIZINE HYDROCHLORIDE | 12.5MG | tablet · oral | ABC HOLDING | Discontinued | 7 Feb 1977 |
| MECLIZINE HYDROCHLORIDE | 25MG | tablet · oral | ABC HOLDING | Discontinued | 15 Feb 1977 |
| MECLIZINE HYDROCHLORIDE | 25MG | tablet · oral | KV PHARM | Discontinued | 3 Jun 1977 |
| MECLIZINE HYDROCHLORIDE | 12.5MG | tablet · oral | KV PHARM | Discontinued | 8 Jun 1977 |
| MECLIZINE HYDROCHLORIDE | 25MG | tablet · oral | ANI PHARMS | Discontinued | 6 Jul 1977 |
| MECLIZINE HYDROCHLORIDE | 25MG | tablet · oral | ANABOLIC | Discontinued | 31 May 1978 |
| MECLIZINE HYDROCHLORIDE | 25MG | tablet · oral | BUNDY | Discontinued | 12 Jul 1978 |
| MECLIZINE HYDROCHLORIDE | 25MG | tablet, chewable · oral | NEXGEN PHARMA INC | Discontinued | 14 Sep 1978 |
| MECLIZINE HYDROCHLORIDE | 25MG | tablet · oral | VANGARD | Discontinued | 4 Jan 1982 |
15 more — full table
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | MECLIZINE 12.5 MG CAPLET | $0.03127 | per EA | 23 Sep 2026 |
| US NADAC | MECLIZINE 12.5 MG TABLET | $0.04419 | per EA | 23 Sep 2026 |
| US NADAC | MECLIZINE 12.5 MG TABLET | $0.03127 | per EA | 23 Sep 2026 |
| US NADAC | MECLIZINE 25 MG TABLET | $0.07568 | per EA | 23 Sep 2026 |
| US NADAC | MECLIZINE 25 MG TABLET | $0.12808 | per EA | 23 Sep 2026 |
| US NADAC | MECLIZINE 25 MG TABLET CHEW | $0.03334 | per EA | 23 Sep 2026 |
| US NADAC | MECLIZINE 50 MG TABLET | $2.48424 | per EA | 7 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 28 Jun 2019 ANTIVERT — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.